AcelRx Pharmaceuticals (ACRX) shares rose strongly in trading today. The company received initial coverage from Credit Suisse, with an outperform rating and $7 price target. ACRX recently received FDA approval in late 2018 for its powerful opioid DSUVIA. The company insists that it will tightly regulate the distribution and dosage so as to avoid patients becoming addicted to the drug. Here’s a recap.
Written By: Howard Greenberg As everyday traders put their trading plans into action for 2026, penny stocks might not be on many of their radars. It’s totally understandable why penny stocks may not appeal to the more calculated seasoned traders. Their reputations for susceptibility to manipulation, extreme volatility, and low liquidity make them way too […]
Read Article
A high-profile policy debate has re-entered the financial spotlight surrounding credit card interest rate caps. Last week, President Donald Trump called for a temporary national cap on credit card interest rates. He proposed a maximum annual rate of 10% over a one-year period, starting January 20, 2026. President Trump’s proposal would aim to combat the […]
Read Article
What is Prop Trading? Prop trading has exploded in popularity over the last five years. It’s transformed from a niche practice into a mainstream gateway for retail traders. There’s a lot of highly skilled traders out there who are sitting on the sidelines right now for two main reasons: Prop trading addresses both issues. In […]
Read Article
When asked about kicking off market action for this week, Scott Bauer gave a very blunt answer: “Volatility, and we don’t know what’s next.” That first question kicked off Scott’s most recent appearance on the Schwab Network’s “Big 3” segment earlier this week. Scott touched on the unpredictable landscape traders are currently facing, and highlighted […]
Read Article
When Bad is Bad Wall Street’s three main indexes closed down on Friday amid a sudden setback in the U.S. labor market and a 12% spike in U.S. oil prices due to the escalating conflict in the Middle East. Oil prices rose more than 36% this week. Sometimes “bad” economic data can be “good” for […]
Read Article
In 2025, over $3.4 billion was reportedly stolen from crypto wallets—a record high. Storage security for cryptocurrency is a growing concern among traders of digital currencies like Bitcoin, Ethereum, and other altcoins. While many developers of crypto wallets are constantly working to stay ahead of the sophisticated capabilities hackers possess, many industry experts fear the […]
Read ArticleWe choose to let our members and students speak for themselves. We do not actively solicit testimonials, no compensation has been paid for any testimonial, and testimonials are not necessarily representative of the experience of all students. All monetary claims made in testimonials that you see depicted in our marketing material have been verified by Prosper Trading Academy and attested to by the members that have given them. Verified testimonials encompass “experience” reviews that highlight the personal experiences of working with our team and “performance” testimonials where we verify trading success of students who have enrolled in our programs.Given the broad reach of the internet, testimonials and reviews of our programs that we have not been able to verify can be found on various websites across the internet which are beyond our editorial control. While we do very much enjoy hearing positive things from our students and it is critical to our mission that everyone is satisfied with their journey with Prosper, we encourage you to take both verified and unverified testimonials for what they are.